Crown Jewel Defense Against Hostile Takeovers

A crown jewel defense against hostile takeovers is a tactic in which a company facing an unwanted bidder sells off or grants options on its most valuable subsidiaries or business units to make the acquisition less attractive. The strategy works by eroding the target’s appeal—once the bidder loses access to the assets that made the deal lucrative, the cost-benefit math shifts.

How the Crown Jewel Defense Works

When a hostile bidder submits an unwelcome offer, the target company’s board faces a race against time. One aggressive option is to strip away the assets that made the company valuable in the first place. If the bidder was drawn to a high-margin subsidiary, a profitable brand, or a portfolio of patents, selling or pledging those units to a friendlier third party can obliterate the deal’s logic. The bidder is left with a hollowed shell—the “crown jewel” is now owned by someone else, and the remaining business may no longer justify the acquisition price.

In practice, the crown jewel defense can take two forms. A outright sale transfers the asset immediately to a white knight (a friendly buyer who often then swoops in to acquire the whole company) or a strategic buyer. A put option grants the third party the right to buy the asset at a preset price, usually triggered if the hostile bidder succeeds; this delays the sale and reserves optionality. Either way, the effect is the same: the hostile bidder’s prize is locked away.

Why Courts Scrutinize These Moves

The crown jewel defense sits in a gray zone under Delaware corporate law, which governs most major U.S. corporations. Directors have a business judgment rule that shields them from liability when they act in good faith on reasonable information—but a fire-sale of the company’s crown jewel to an insider’s friend can invite shareholder litigation. Courts ask whether the board genuinely believed the hostile bid would destroy shareholder value, or whether they simply disliked the bidder and acted to entrench themselves.

Key questions a court examines:

• Did the board have “reasonable grounds” to believe the hostile bid was inadequate or coercive?
• Was the asset sale negotiated at arm’s length, or was it a sweetheart deal?
• Did the board exhaust less drastic defenses first, or did it leap to the nuclear option?
• Did the white knight emerge before the sale, or was the asset essentially given away to create a knight?

If the board failed these tests, shareholders can challenge the defense in litigation, sometimes successfully recovering the company or extracting damages.

The White Knight Strategy

Often, the crown jewel defense and the white knight acquisition arrive as a package. A board, facing hostile pressure, quietly approaches a more palatable bidder and offers to sell the most attractive assets to that bidder if it will then acquire the whole company—or at least mount a counterbid. The white knight buys the crown jewels, the hostile bidder loses interest, and the white knight either takes over the company or negotiates a friendly merger.

This was common in the 1980s and 1990s, when hostile takeovers peaked. A board would license patents to a white knight, then accept that knight’s offer for the full company. Modern boards, however, increasingly use this defense only when a bid is truly seen as inadequate—the reputational and legal costs are high.

Practical Outcomes and Shareholder Cost

The irony is sharp: the crown jewel defense saves the company from a hostile takeover by selling off the company’s most profitable pieces. If the defense works, the hostile bidder vanishes, but the board has surrendered the business units that generated the bulk of cash flow. Shareholders end up with a smaller, less valuable company—albeit under friendly management.

In some cases, shareholders later regret the asset sale more than they would have regretted accepting the original hostile bid. The company shrinks but stays independent, or a white knight takes it over at a lower total price than the original bidder might have paid if the crown jewels had remained intact. This is why courts now demand that boards prove the sale was genuinely necessary to reject an inadequate offer, not a mere pretext for entrenchment.

Modern Alternatives and Declining Use

Today’s hostile takeover defenses have evolved. Most public companies adopt poison pills (rights plans that dilute a bidder’s stake), and boards are more comfortable negotiating directly with large shareholders. The crown jewel defense has become a last resort, used mainly when a company believes a hostile bidder is trying to dismantle and sell the business piecemeal and that a negotiated white knight transaction is the lesser evil.

Real estate investment trusts (REITs) and diversified industrials are most likely to face crown jewel scenarios, since they own discrete, valuable subsidiaries. In contrast, integrated technology or healthcare companies rarely use it—their value is diffused across operating divisions, and selling off pieces makes less strategic sense.

See also